Every 8-K that YIJIA GROUP CORP (YJGJ) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow YJGJ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full YJGJ filings page.
VitaNova Life Sciences Corporation, formerly Yijia Group Corp., reports that its corporate name change and a reverse stock split have now been cleared for trading purposes. The Certificate of Amendment filed in Nevada on January 9, 2026 changed the name to VitaNova Life Sciences Corporation and implemented a 1‑for‑3 reverse stock split, so each stockholder receives one share for every three previously held.
FINRA has completed its review, and both the name change and reverse split take effect on the OTC Pink marketplace as of January 27, 2026. The company’s common stock will trade under the symbol YJGJD for 20 trading days beginning January 27, 2026, after which the ticker will change to VNOV. The company has also obtained a new CUSIP number, 98585W403. The company states that no action is required by current stockholders in relation to these changes.
Yijia Group Corp. is changing its corporate structure and capital setup. The company has filed a Certificate of Amendment in Nevada to change its name to VitaNova Life Sciences Corporation, with the filing effective January 9, 2026, while FINRA processes the name change. In connection with these actions, the company has obtained a new CUSIP number, 98585W403, for its common stock and plans to adopt a new ticker symbol, which it is still evaluating.
The amendment also implements a 1-for-3 reverse stock split, so each stockholder will receive one share of common stock for every three shares held. Earlier, the company increased its authorized capital to 210,000,000 shares, including 200,000,000 common shares and 10,000,000 preferred shares, and designated 3,000,000 of those preferred shares as Series A Preferred Stock with specific rights and preferences approved by the board and majority stockholders.
Yijia Group Corp. plans several major corporate changes. The company intends to change its name to VitaNova Life Sciences Corporation, with a new ticker symbol to follow on OTC Markets; until then, its common stock will continue trading under YJGJ with the current CUSIP.
The board and a majority of common shareholders have approved a reverse stock split in a ratio range of 1-for-2 to 1-for-3, meaning each shareholder would receive one new share for every two or three existing shares once the final ratio is set. They also approved an increase in authorized capital to 85,000,000 shares, consisting of 75,000,000 common and 10,000,000 preferred shares, and the creation of blank check preferred stock that the board can designate into series with different rights over time. These changes will be implemented by filing a Certificate of Amendment with the Nevada Secretary of State after the reverse split ratio is finalized.